FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

19 results

abrilada
(adalimumab-afzb)
Pfizer Laboratories Div Pfizer Inc
Usage: ABRILADA is indicated for the treatment of various conditions, including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, moderate to severe chronic plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and certain pediatric patients.
abrilada
(adalimumab-afzb)
Pfizer Laboratories Div Pfizer Inc
Usage: ABRILADA is indicated for treating moderately to severely active rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and pediatric patients.
adalimumab
(adalimumab-fkjp)
Biocon Biologics Inc
Usage: Adalimumab-fkjp is indicated for treating moderate to severe rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and pediatric patients (ages vary by condition).
adalimumab
(adalimumab-adaz)
Sandoz Inc
Usage: Adalimumab-adaz is indicated for adults with moderate to severe chronic plaque psoriasis who require systemic therapy or phototherapy, and when other systemic treatments are less suitable. Patients must be closely monitored and have regular physician follow-ups.
adalimumab-ryvk
(adalimumab-ryvk)
Quallent Pharmaceuticals Health LLC
Usage: Adalimumab-ryvk is indicated for various conditions, including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis, aiming to reduce symptoms and inhibit disease progression.
amjevita
(adalimumab-atto)
Optum Health Solutions (Ireland) Limited
Usage: AMJEVITA is indicated for various conditions including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, chronic plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis, either alone or in combination with other therapies.
amjevita
(adalimumab-atto)
Amgen Inc
Usage: AMJEVITA is indicated for treating various conditions, including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and pediatric patients, depending on the specific condition.
avsola
(infliximab-axxq)
Amgen Inc
Usage: AVSOLA is indicated for reducing signs and symptoms, inducing and maintaining remission in moderately to severely active Crohn's disease (adult and pediatric), ulcerative colitis (adult and pediatric), and other conditions like rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and chronic severe plaque psoriasis.
cyltezo
(adalimumab-adbm)
Boehringer Ingelheim Pharmaceuticals, Inc.
Usage: CYLTEZO is indicated for treating moderately to severely active rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, chronic plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and pediatric patients aged 2 and older.
enbrel
(etanercept)
Immunex Corporation
Usage: Enbrel is indicated for reducing signs and symptoms in rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, chronic moderate to severe plaque psoriasis, and active juvenile psoriatic arthritis in patients aged 2 and older, with or without methotrexate.

Tumor Necrosis Factor Blocker class drugs

abrilada

abrilada

adalimumab

adalimumab

adalimumab-ryvk

amjevita

amjevita

avsola

cyltezo

enbrel